Evaluation of curative effects of royal jelly on orofacial pain with a compact electroencephalograph

Evaluation of curative effects of royal jelly on orofacial pain with a compact electroencephalograph - Effects of royal jelly on orofacial pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006984

Enrollment

Registered

2011-12-28

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orofacial pain

Interventions

Royal jelly 1: 3 Tab/day, 28 days Royal jelly 2: 6 Tab/day, 28 days Royal jelly placebo 1: 3 Tab/day, 28 days Royal jelly placebo 2: 6 Tab/day, 28 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Orofacial pain

Exclusion criteria

Exclusion criteria: Diabetes mellitus, Psychiatric disease, Food allergy, Asthma

Design outcomes

Primary

Measure	Time frame
Visual analogue scale alpha wave beta wave gamma wave theta wave	—

Secondary

Measure	Time frame
Horner's symptom	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026